Hey everybody. This is Alex. Hey, it's Natasha. And we are here to talk just for a second about Extra Crunch, Tech Crunchy subscription product. Extra Crunch is where a lot of our best analysis and follow-up stories lives. We focus a lot on startups, building, and even poke fun here and there.

It's true. I also write a daily column called The Exchange that's over on Extra Crunch

and the good news is if you don't have

EC access yet we have a deal for you. Yes you can use I think the best code

there is so don't tell anyone who doesn't listen to equity because they're not invited the code is equity all caps for 50% off your extra crunch subscription

So head over to techwrench.com slash subscribe use that code make us look good internally we say

thanks across the internet and now let's do a show. Hello and welcome back to Equity Tech Runches Venture Capital Focus Podcast, where we unpack the numbers behind the headlines.

My name is Alex Wilhelm and I am joined today as always by my two absolute favorites.

I have Natasha Moskarenas here.

Natasha, you are in Jersey, life is good, we're vaccinated.

How you feeling?

I'm feeling good.

I'm rocking a high pony today, so feeling better than usual.

With, with, let's go ahead and say it is scrunchy which you are trying to quote quote

bring back up here it's back it's back everyone put them on if you have hair

Natasha told me before the show started that I was not invited to the scrunchy party

because I'm bald which I thought was rude.

We also have Danny Crayin here.

Dana, you have hair.

How are you doing?

I'm in New York City and I realize today that Claritin no longer works on allergies.

Are you taking Claritin D or non-Clerton D? I think I took all the above.

...